Due to encouraging pre‐clinical data and supportive observational studies, there has been growing interest in applying cardiovascular drugs (including aspirin, angiotensin‐converting enzyme [ACE] inhibitors, statins, and metformin), approved to treat diseases such as hypertension, hyperlipidemia, and diabetes mellitus, to the field of oncology.8 This evidence concerns the gene ACE and hyperlipidemia.